The generation of AD mouse models is often achieved via the introduction of mutations to the amyloid precursor protein (APP) gene, the presenilin 1 (PS1) gene, or the insertion of a human tau (hTau) transgene (Paulson et al., 2008). Here, MAPT is linked to Alzheimer disease.